3. Stryker Corporation (NYSE:SYK)
Stryker Corporation (NYSE: SYK) ranks third among the 10 robotics stocks to buy now as Amazon.com, Inc. (NASDAQ: AMZN) hits 1 million robots. Trading at $326.54, with the stock up 4.20%, Stryker Corporation (NYSE: SYK) has a short percentage of float of 1.70% and is backed by 81 hedge fund holders. Stryker Corporation (NYSE: SYK) is one of the strongest medical technology names in the robotics market because it gives investors exposure to surgical robotics, orthopedic devices, hospital equipment, and advanced medical systems.
Stryker Corporation (NYSE: SYK) develops, manufactures, and markets specialized medical devices, equipment, and implants. Its products are broadly divided into Orthopedics, MedSurg, and Neurotechnology and Spine. The company is especially important in the robotics investment theme because of its Mako robotic system, which has become a leading platform in robotic-assisted procedures. In healthcare, robotics is not just about efficiency. It is about precision, consistency, surgeon support, patient outcomes, and the ability to make complex procedures more predictable. That is why surgical robotics stocks remain one of the most attractive corners of the robotics industry.
On June 12, BTIG analyst Ryan Zimmerman reiterated a Buy rating on Stryker Corporation (NYSE: SYK) and assigned a $379 price target. The bullish stance came as Stryker Corporation (NYSE: SYK)’s Mako robotic system continued to gain traction as a leading platform for ambulatory surgery centers. This is important because ambulatory surgery centers are becoming a bigger part of healthcare delivery. They can offer lower-cost settings for certain procedures, and robotic systems can help improve surgical planning and execution. Stryker Corporation (NYSE: SYK) is increasingly capitalizing on robotics in the healthcare sector as robotic-assisted systems shift from discretionary technology to baseline equipment.
The adoption story is also changing culturally inside healthcare. Young surgeons are increasingly treating robotic systems as a baseline requirement, while patients are becoming more aware of and more interested in robotic-assisted procedures. This creates a strong demand backdrop for Stryker Corporation (NYSE: SYK)’s robotics platform. The company’s flexible contract structures, including volume-based agreements and walk-away clauses, are also helping fuel robotics adoption for ambulatory surgery centers by lowering financial risk barriers. In simple terms, Stryker Corporation (NYSE: SYK) is making it easier for surgical centers to say yes to robotics.
Earlier, on May 26, Stryker Corporation (NYSE: SYK) launched its Pangea Plating System in Europe to treat a wide range of fracture patterns. The system includes plates and complementary instrumentation intended to support plate fit and provide surgeons with options for fracture fixation. While the Pangea Plating System is not the same as the Mako robotic system, it reinforces Stryker Corporation (NYSE: SYK)’s broader medical technology strength. For investors looking for the best robotics stocks to buy, Stryker Corporation (NYSE: SYK) offers a healthcare-focused robotics angle that is very different from warehouse automation, industrial robotics, and AI chip platforms.
Click next to see the following stock...
